Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001140361-16-052289
Filing Date
2016-02-12
Accepted
2016-02-12 16:31:41
Documents
1
Group Members
SAK CORPSETH A. KLARMAN

Document Format Files

Seq Description Document Type Size
1 NONE doc1.htm SC 13G/A 115562
  Complete submission text file 0001140361-16-052289.txt   117138
Mailing Address 10 ST JAMES AVE SUITE 1700 BOSTON MA 02116
Business Address 10 ST JAMES AVE SUITE 1700 BOSTON MA 02116 617-210-8300
BAUPOST GROUP LLC/MA (Filed by) CIK: 0001061768 (see all company filings)

EIN.: 043402144 | State of Incorp.: MA
Type: SC 13G/A

Mailing Address 701 GATEWAY BLVD SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD SUITE 200 SOUTH SAN FRANCISCO CA 94080 650-278-8930
Atara Biotherapeutics, Inc. (Subject) CIK: 0001604464 (see all company filings)

EIN.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88393 | Film No.: 161419785
SIC: 2836 Biological Products, (No Diagnostic Substances)